These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13192203)

  • 1. The mode of action of phenylindanedione.
    WALKER W; HUNTER RB
    J Clin Pathol; 1954 Aug; 7(3):249-51. PubMed ID: 13192203
    [No Abstract]   [Full Text] [Related]  

  • 2. The comparative action of dicumarol and of phenylindanedione on the coagulase reacting factor and on prothrombin.
    TAGER M
    Yale J Biol Med; 1953 Apr; 25(5):374-82. PubMed ID: 13057268
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of phenylindanedione on the coagulation factors prothrombin, factor V and factor VII and the question of vitamin K resistance].
    PERLICK E
    Klin Wochenschr; 1953 Mar; 31(11-12):261-3. PubMed ID: 13070456
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effects of phenylindanedione on blood coagulation].
    CASULA D
    Rass Med Sarda; 1955; 57(3-4):153-62. PubMed ID: 13290063
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research on anticoagulant effect of phenylindanedione and its relation to the substances with vitamin P effect].
    LONGO G
    Haematologica; 1954; 38(9):1161-8. PubMed ID: 13221125
    [No Abstract]   [Full Text] [Related]  

  • 7. Prothrombin level during phenylindandione therapy; influence of the condition of the liver.
    TAWAST M; SIURALA M
    Ann Med Intern Fenn; 1955; 44(4):237-43. PubMed ID: 13327567
    [No Abstract]   [Full Text] [Related]  

  • 8. Mode of action of coumarin drugs.
    DOUGLAS AS
    Br Med Bull; 1955; 11(1):39-44. PubMed ID: 13230473
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the hypoprothrombinemic effect of 2-naphthoxyindandione-(1,3) and 2-tetrahydronaphthylindandiones-(1,3). 30. On the phthalides and indandiones].
    Hrnciar P; Lácová M; Kovalcík V
    Pharmazie; 1968 Sep; 23(9):499-500. PubMed ID: 5717188
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical evaluation of three anticoagulants in thrombo-embolic disease.
    NEILSON JM; MOLLISON AW
    Br Med J; 1957 May; 1(5029):1214-7. PubMed ID: 13426587
    [No Abstract]   [Full Text] [Related]  

  • 11. The anticoagulant effect of phenylindanedione in thromboembolic disorders.
    BROWN KW; MACMILLAN RL
    Am J Med Sci; 1953 May; 225(5):495-500. PubMed ID: 13040333
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on the anticoagulant phenindione. IV. Its multiphasic effect on the coagulation mechanism.
    ADAMIS D; KIMBALL D; SISE HS
    J Lab Clin Med; 1957 Jan; 49(1):69-83. PubMed ID: 13385578
    [No Abstract]   [Full Text] [Related]  

  • 13. Anticoagulant activities of some 2-acyl-1, 3-indandiones.
    Bond HW; Dedhiya MG; Carlson GP
    Arch Int Pharmacodyn Ther; 1973 Jun; 203(2):288-91. PubMed ID: 4800265
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of administration of phenindione on blood levels of prothrombin, autoprothrombin I and autoprothrombin II.
    JOHNSON SA; CALDWELL MJ; PRIEST EM
    J Appl Physiol; 1958 Nov; 13(3):411-6. PubMed ID: 13587424
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of 2-phenyl-1-3-diketohydrindene on blood coagulation].
    SCHMID J; VINAZZER H
    Wien Z Inn Med; 1953 May; 34(5):194-9. PubMed ID: 13090767
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of the anticoagulant diphenadione on suckling calves.
    Elias DJ; Thompson RD; Savarie PJ
    Bull Environ Contam Toxicol; 1978 Jul; 20(1):71-8. PubMed ID: 581268
    [No Abstract]   [Full Text] [Related]  

  • 17. Tolerance to phenindione of patients with different thromboembolic disorders.
    Nour-Eldin F; Lewis FJ
    Acta Haematol; 1964 Dec; 32(6):338-47. PubMed ID: 5005471
    [No Abstract]   [Full Text] [Related]  

  • 18. A one stage method for the assay of antihemophilic factor B (AHF B) with a comment on the antihemophilic factor B (AHF B) concentration in phenylindanedione (PID) therapy.
    STAPP WF
    Scand J Clin Lab Invest; 1958; 10(2):169-76. PubMed ID: 13602673
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical and experimental results with a new anticoagulant phenylindanedione; with a study on clarification of the mechanism of action on prothrombin, factor V and factor VII content of the blood coagulating system].
    JURGENS J
    Z Gesamte Inn Med; 1953 Apr; 8(7):288-98. PubMed ID: 13170040
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of 5-hydroxytryptamine on bleeding time, coagulation time, prothrombin time and Howell's time].
    DONATI V; BONTEMPI ME
    Boll Soc Med Chir Cremona; 1955 Nov; 10(2):130-5. PubMed ID: 13315820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.